Bp PLC Novo Cure LTD Transaction History

Bp PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$116.17 - $194.55 $261,266 - $437,542	-2,249 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$130.4 - $225.58 $110,709 - $191,517	-849 Reduced 27.4%	2,249 $499,000
Q1 2021 May 13, 2021	BUY	$124.11 - $190.17 $101,025 - $154,798	814 Added 35.64%	3,098 $409,000
Q4 2020 Feb 08, 2021	BUY	$112.16 - $174.14 $256,173 - $397,735	2,284 New	2,284 $396,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

Stay updated on Bp PLC with notifications on news.